Can a patient with an Implantable Cardioverter-Defibrillator (ICD) still die?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Patients with ICDs Still Die?

Yes, patients with implantable cardioverter-defibrillators (ICDs) can still die despite having the device implanted. While ICDs are effective at terminating life-threatening ventricular arrhythmias, they cannot prevent all causes of death 1.

Mechanisms of Death in ICD Recipients

Arrhythmic Death Despite ICD

  • ICDs are designed to detect and treat ventricular tachyarrhythmias but may fail to prevent death due to:
    • Protracted arrhythmias requiring multiple shocks that ultimately lead to hemodynamic collapse 2
    • Arrhythmias that are resistant to defibrillation therapy
    • Device failures (though rare with modern ICDs)

Non-Arrhythmic Causes of Death

  • Progressive heart failure (most common non-arrhythmic cause) 1
  • Acute myocardial infarction 2
  • Non-cardiac causes (stroke, malignancy, multi-organ failure) 3
  • End-stage heart disease progression 1

Clinical Context and Risk Factors

Heart Failure Progression

  • The ACC/AHA guidelines note that as heart failure advances to persistent or frequently recurrent Class IV symptoms, the proportion of deaths prevented by ICDs declines 1
  • In advanced heart failure, death from pump failure becomes more likely than sudden arrhythmic death 1
  • Approximately 30% of ICD patients may experience arrhythmic events in their final days of life 3

Timing Considerations

  • The absolute risk of sudden death is highest in patients with severe symptoms (Stage D heart failure) 1
  • Many patients with end-stage symptoms experience "sudden death" that is nonetheless expected due to disease progression 1

Specific Patient Populations

Post-Myocardial Infarction

  • Patients within 40 days of an MI remain at risk despite ICD implantation 1
  • The HRS/ACC/AHA guidelines note that ICDs are not recommended for patients resuscitated from cardiac arrest due to ventricular tachyarrhythmia related to acute MI if they have normal LV function and complete coronary revascularization 1

Transplant Candidates

  • Patients awaiting cardiac transplantation have high mortality risk despite ICD implantation 1
  • ICDs serve as a bridge to transplantation but cannot eliminate all mortality risk 1

Practical Implications

Device Deactivation at End of Life

  • As disease progresses, inappropriate or even appropriate ICD shocks may no longer prolong life and can reduce quality of life 3
  • Palliative care discussions should include consideration of ICD deactivation when death from non-arrhythmic causes becomes inevitable 3

Limitations of ICD Protection

  • The ESC guidelines acknowledge that while ICDs prevent sudden death and prolong life in high-risk patients, this benefit only applies when patients do not suffer from other conditions that limit life expectancy to less than 1-2 years 1

Key Takeaways

  • ICDs are highly effective at terminating ventricular arrhythmias but cannot prevent all causes of death
  • In a study of sudden deaths among ICD recipients, 64% were tachyarrhythmia-associated, with the device ultimately terminating the arrhythmia in 94% of these cases, yet death still occurred 2
  • As heart failure progresses, the relative contribution of preventable sudden death to overall mortality decreases 1
  • Multiple clinical factors can contribute to death despite ICD therapy, including heart failure exacerbation, acute ischemia, and electrolyte abnormalities 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Implantable cardiac device deactivation at the end of life].

Giornale italiano di cardiologia (2006), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.